Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

27.11.19	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
20.11.19	Biosimilar Race: U.S. Lags Behind Europe (RTTNews)
19.11.19	KRTX Makes Giant Leap, The Medicines' Working Well, AGRX On The Move (RTTNews)
18.11.19	FDA Approves Pfizer's ABRILADA, Fifth Biosimilar To Humira (RTTNews)
18.11.19	Pfizer: FDA Approves ABRILADA As Biosimilar To Humira - Quick Facts (RTTNews)
18.11.19	FDA Approves Pfizer’s Biosimilar, ABRILADA™ (adalimumab-afzb) for Multiple Inflammatory Conditions (Businesswire)
15.11.19	Bristol-Myers Squibb and Pfizer Announce Randomized, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals (Businesswire)
12.11.19	Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination (Businesswire)
29.10.19	Pfizer Q3 Profit Rises; Lifts 2019 Profit View (RTTNews)
29.10.19	Pfizer Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
29.10.19	PFIZER REPORTS THIRD-QUARTER 2019 RESULTS (Businesswire)
28.10.19	Biotech Stocks Facing FDA Decision In November 2019 (RTTNews)
14.10.19	ImaginAb, AstraZeneca, Pfizer, Takeda Join To Develop CD8 ImmunoPET Technology (RTTNews)
12.10.19	Pfizer Presents Positive Phase 3 Data at the 28th Congress of the European Academy of Dermatology and Venereology for Abrocitinib in Moderate to Severe Atopic Dermatitis (Businesswire)
30.09.19	Pfizer: Interim BEACON CRC Data Shows Encouraging Potential For BRAFTOVI Triplet (RTTNews)
27.09.19	Pfizer Inc. Awards "Golden Tickets” to Neutrolis and Mediar Therapeutics (Businesswire)
27.09.19	Pfizer Names CEO Albert Bourla To Succeed Ian Read As Chairman - Quick Facts (RTTNews)
27.09.19	Ian Read to Retire as Executive Chairman of Pfizer’s Board of Directors; Chief Executive Officer Dr. Albert Bourla Named Chairman (Businesswire)
27.09.19	Pfizer Announces Positive Top-Line Results On Abrocitinib (RTTNews)
24.09.19	Pfizer Declares Fourth-Quarter 2019 Dividend (Businesswire)
24.09.19	Pfizer Presents New Evidence of IBRANCE® (palbociclib) Effectiveness in HR+, HER2- Metastatic Breast Cancer Patients in Four Real-World Studies at ESMO Congress 2019 (Businesswire)
19.09.19	Pfizer Presents Scientific Advancements in Cancer Care at the ESMO Congress 2019 Highlighting Expanded Portfolio (Businesswire)
17.09.19	Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call With Analysts (Businesswire)
09.09.19	Pfizer Reports Positive Results From Phase 2 Study Of 20vPnC Vaccine Candidate (RTTNews)
03.09.19	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
22.08.19	Pfizer To Invest $500 Mln In Gene Therapy Manufacturing Plant (RTTNews)
21.08.19	U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer (Businesswire)
21.08.19	Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina (Businesswire)
16.08.19	Pfizer Recalls Migraine Tablets Over Concerns Of Bacterial Infection (RTTNews)
03.08.19	Pfizer Announces Phase 3 Top-Line Results for Rivipansel in Patients with Sickle Cell Disease Experiencing a Vaso-Occlusive Crisis (Businesswire)
01.08.19	AMRN'S Vascepa Hits Record Sales, ADMP Slumps On Stock Offering, SRDX On Watch… (RTTNews)
01.08.19	Pfizer Closes JV With GlaxoSmithKline, Forms GSK Consumer Healthcare (RTTNews)
01.08.19	Pfizer Announces Closing of Joint Venture With GlaxoSmithKline to Create a Premier Global Consumer Healthcare Company (Businesswire)
30.07.19	Pfizer Completes Acquisition of Array Biopharma (Businesswire)
29.07.19	Pfizer Acquires Mylan And The EpiPen (RTTNews)
29.07.19	Pfizer Q2 Revenues Up 2% Operationally; Updates 2019 Guidance (RTTNews)
29.07.19	Biotech Stocks Facing FDA Decision In August 2019 (RTTNews)
29.07.19	Mylan, Pfizer Upjohn To Combine To Create New Global Pharma Company (RTTNews)
29.07.19	Pfizer Inc. Reschedules Second-Quarter 2019 Earnings Conference Call to July 29, 2019 at 10:30 a.m. EDT (Businesswire)
29.07.19	PFIZER REPORTS SECOND-QUARTER 2019 RESULTS (Businesswire)
29.07.19	Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World’s Need for Medicine (Businesswire)
29.07.19	GSK: ViiV Submits Regulatory Application To EMA For Cabotegravir HIV Injection (RTTNews)
28.07.19	Pfizer Reportedly In Talks To Merge Off-patent Assets With Mylan (RTTNews)
26.07.19	Notable Earnings To Watch Next Week - LLY, AAPL, PG, MRK, PFE, CVX (RTTNews)
23.07.19	FDA Approves Pfizer’s Biosimilar, RUXIENCE™ (rituximab-pvvr), for Certain Cancers and Autoimmune Conditions (Businesswire)
03.07.19	ViiV Healthcare Reports Marketing Authorisation Of Dovato In Europe (RTTNews)
01.07.19	PFIZER SCHLIESST DIE AKQUISITION VON THERACHON AB (Businesswire)
01.07.19	Pfizer Completes Acquisition of Therachon (Businesswire)
01.07.19	Pfizer Reports Positive Findings From Phase 4 Crisaborole Study - Quick Facts (RTTNews)
01.07.19	Pfizer Announces Positive Top-Line Results from Phase 4 Study of Crisaborole Ointment, 2%, in Children Aged 3 Months to Less Than 24 Months with Mild to Moderate Atopic Dermatitis (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	76.62	0.39 %	K V
Part Grp Hldg	1’271.50	0.36 %	K V
Holcim	89.08	0.25 %	K V
Logitech Intl	74.82	-0.05 %	K V
Lonza Grp	540.60	-0.15 %	K V
UBS Group	27.82	-1.24 %	K V
Sika	223.10	-1.37 %	K V
Nestle	74.10	-1.49 %	K V
Swiss Re	129.60	-1.78 %	K V
Givaudan	3’961.00	-2.46 %	K V

mehr

18.12.24		Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten
18.12.24		Pluszeichen in Europa: STOXX 50 letztendlich fester
18.12.24		Minuszeichen in Zürich: SMI legt letztendlich den Rückwärtsgang ein
18.12.24		Börse Zürich in Rot: SPI schliesst in der Verlustzone
18.12.24		Handel in Europa: Euro STOXX 50 präsentiert sich letztendlich fester
18.12.24		Freundlicher Handel in London: FTSE 100 notiert zum Ende des Mittwochshandels im Plus
18.12.24		Zuversicht in Frankfurt: Zum Ende des Mittwochshandels Pluszeichen im TecDAX
18.12.24		Aufschläge in Frankfurt: SDAX steigt zum Handelsende

18.12.24

Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten

18.12.24

Pluszeichen in Europa: STOXX 50 letztendlich fester

18.12.24

Minuszeichen in Zürich: SMI legt letztendlich den Rückwärtsgang ein

18.12.24

Börse Zürich in Rot: SPI schliesst in der Verlustzone

18.12.24

Handel in Europa: Euro STOXX 50 präsentiert sich letztendlich fester

18.12.24

Freundlicher Handel in London: FTSE 100 notiert zum Ende des Mittwochshandels im Plus